Retacrit® Epoetin Alfa-epbx 4,000 U/mL Injection for Anemia Management

USAMP#37688197SKU: 00069130710Retacrit®
rxLicense

License Required

wishlistAltwishlistAlt
Retacrit Epoetin Alfa-epbx 4,000 U/mL Injection - Pfizer Biosimilar

Product Spotlight

  • Epoetin Alfa-epbx 4,000 U/mL single-dose vial for precise dosage.
  • Manufactured by Pfizer Biosimilar, ensuring high-quality and reliability.
  • Designed for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use in certain surgeries to reduce the need for blood transfusions.
  • Easy-to-use injection form for efficient administration.
  • Requires refrigeration to maintain its efficacy and stability.
  • Latex-free product, suitable for patients with latex allergies.

More Information

SDS